Gm-Csf
Transplantation, Stem Cell
M.D. Anderson Cancer CenterPhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
75 Active assets in the Transplantation, Stem Cell cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Busulphan Institute of Hematology & Blood Diseases Hospital, China | Phase 3 | BBB |
Cyclophosphamide The First Affiliated Hospital of Soochow University | Phase 3 | BBB |
FILGRASTIM National Cancer Institute (NCI) | Phase 2/3 | BBB |
Decitabine Chinese PLA General Hospital | Phase 4 | BBB |
Cyclophosphamide St. Jude Children's Research Hospital | Phase 3 | BBB |
View all 50 →
Same molecule, other indications
Gm-Csf is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →